Correlation Between GlaxoSmithKline PLC and Multi Medika
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Multi Medika at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Multi Medika into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Multi Medika Internasional, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Multi Medika and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Multi Medika. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Multi Medika.
Diversification Opportunities for GlaxoSmithKline PLC and Multi Medika
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between GlaxoSmithKline and Multi is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Multi Medika Internasional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Multi Medika Interna and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Multi Medika. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Multi Medika Interna has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Multi Medika go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Multi Medika
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Multi Medika. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 3.11 times less risky than Multi Medika. The stock trades about -0.11 of its potential returns per unit of risk. The Multi Medika Internasional is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 5,100 in Multi Medika Internasional on August 27, 2024 and sell it today you would earn a total of 3,100 from holding Multi Medika Internasional or generate 60.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Multi Medika Internasional
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Multi Medika Interna |
GlaxoSmithKline PLC and Multi Medika Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Multi Medika
The main advantage of trading using opposite GlaxoSmithKline PLC and Multi Medika positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Multi Medika can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multi Medika will offset losses from the drop in Multi Medika's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Multi Medika vs. Bakrie Brothers Tbk | Multi Medika vs. Langgeng Makmur Industri | Multi Medika vs. Petrosea Tbk | Multi Medika vs. Graha Layar Prima |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |